| Reported/Total |
---|---|
TITLE, KEYWORDS, ABSTRACT | Â |
Identify article as study of assessing diagnostic accuracy | 7/7 |
Identify article as study of administrative data | 7/7 |
INTRODUCTION: | Â |
State disease identification & validation one of goals of study | 7/7 |
METHODS: | Â |
Participants in validation cohort: | Â |
Describe validation cohort (Cohort of patients to which reference standard was applied) | 7/7 |
Age | 6/7 |
Disease | 6/7 |
Severity | 1/7 |
Location/Jurisdiction | 7/7 |
Describe recruitment procedure of validation cohort | 6/7 |
Inclusion criteria | 6/7 |
Exclusion criteria | 6/7 |
Describe patient sampling (random, consecutive, all, etc.) | 7/7 |
Describe data collection | 7/7 |
Who identified patients and did selection adhere to patient recruitment criteria | 5/7 |
Who collected data | 6/7 |
A priori data collection form | 6/7 |
Disease classification | 7/7 |
Split sample (i.e. re-validation using a separate cohort) | 0/7 |
Test Methods: | Â |
Describe number, training and expertise of persons reading reference standard | 6/7 |
If >1 person reading reference standard, quote measure of consistency (e.g. kappa) | 6/7 |
Blinding of interpreters of reference standard to results of classification by administrative data e.g. Chart abstractor blinded to how that chart was coded | 6/7 |
Statistical Methods: | Â |
Describe methods of calculating/comparing diagnostic accuracy | 7/7 |
RESULTS: | Â |
Participants: | Â |
Report when study done, start/end dates of enrollment | 4/7 |
Describe number of people who satisfied inclusion/exclusion criteria | 6/7 |
Study flow diagram | 2/7 |
Test results: | Â |
Report distribution of disease severity | 1/7 |
Report cross-tabulation of index tests by results of reference standard | 7/7 |
Estimates: | Â |
Report at least 4 estimates of diagnostic accuracy | 5/7 |
Diagnostic Accuracy Measures Resported: | Â |
Sensitivity | 5/7 |
Spec | 5/7 |
PPV | 6/7 |
NPV | 4/7 |
Likelihood ratios | 1/7 |
kappa | 4/7 |
Area under the ROC curve/C-statistic | 0/7 |
Accuracy/agreement | 1/7 |
Report accuracy for subgroups (e.g. age, geography, differen sex, etc.) | 2/7 |
If PPV/NPV reported, ratio of cases/controls of validation cohort approximate prevalence of condition in the population | 2/7 |
Report 95Â % confidence intervals for each diagnostic measure | 5/7 |
DISCUSSION: | Â |
Discuss the applicability of the validation findings | 7/7 |